Investing
24/7 Wall St. Most Overpaid CEO Of The Day: Amylin (AMLN) CEO Daniel M. Bradbury
Published:
Last Updated:
Amylin (AMLN) CEO Dan Bradbury earned a base salary of almost $560,000 last year according to the company proxy. He will probably do as well in 2008.
During the last twelve months, shares in the company are off 40%.
Yesterday, Federal regulators said they are working on a stronger label for a widely used diabetes drug marketed by Amylin Pharmaceuticals Inc. and Eli Lilly & Co. as deaths continue to be reported despite earlier government warnings.
The stock is likely to stay down for a long time
Douglas A. McIntyre
Retirement planning doesn’t have to feel overwhelming. The key is finding expert guidance—and SmartAsset’s simple quiz makes it easier than ever for you to connect with a vetted financial advisor.
Here’s how it works:
Why wait? Start building the retirement you’ve always dreamed of. Click here to get started today!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.